{"id":199874,"date":"2019-06-02T19:23:07","date_gmt":"2019-06-02T23:23:07","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=199874"},"modified":"2019-06-02T19:23:07","modified_gmt":"2019-06-02T23:23:07","slug":"cuban-drug-heberferon-eight-times-more-effective-against-skin-cancer","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/cuban-drug-heberferon-eight-times-more-effective-against-skin-cancer\/","title":{"rendered":"Cuban drug HeberFeron: eight times more effective against skin cancer"},"content":{"rendered":"

HeberFeron, a drug produced by the Cuban Center for Genetic Engineering and Biotechnology, has proven to be eight times more effective for the remission of a type of skin cancer (basal cell carcinoma), according to recent studies released during a scientific event in Holguin<\/span><\/p>\n

According to reports in the Cuban press, HeberFeron, a formulation of interferons that Cuba patented in 2016, cures and reduces skin tumors of any size and obtains better results than other similar medicines.<\/span><\/p>\n

The application of this treatment avoids surgeries, which especially on the face can be very complex.<\/span><\/p>\n

\"\"<\/a>
Photo: guerrillero.cu<\/figcaption><\/figure>\n

The drug reduces the tumoral mass of this type of cancer that often appears on the nose, ears, eyelids and facial areas around the eye.<\/span><\/p>\n

Heberferon directly infiltrates the lesions as an injection and a rapid evolution in the first three weeks has been reported.<\/span><\/p>\n

As described, the cure is reached after 16 weeks of treatment.<\/span><\/p>\n

The use of this medication is widespread in the country and is also applied to eliminate residual or recurrent tumors.<\/span><\/p>\n